BR0008606A - Uso de triazóis fluorados para tratamento de dor e distúrbios afetivos ou de atenção - Google Patents

Uso de triazóis fluorados para tratamento de dor e distúrbios afetivos ou de atenção

Info

Publication number
BR0008606A
BR0008606A BR0008606-1A BR0008606A BR0008606A BR 0008606 A BR0008606 A BR 0008606A BR 0008606 A BR0008606 A BR 0008606A BR 0008606 A BR0008606 A BR 0008606A
Authority
BR
Brazil
Prior art keywords
affective
attention disorders
triazoles
treat pain
fluorinated
Prior art date
Application number
BR0008606-1A
Other languages
English (en)
Inventor
Markus Schmutz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/259,910 external-priority patent/US6156775A/en
Priority claimed from US09/259,911 external-priority patent/US6054471A/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR0008606A publication Critical patent/BR0008606A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Patente de Invenção: "USO DE TRIAZóIS FLUORADOS PARA TRATAMENTO DE DOR E DISTúRBIOS AFETIVOS OU DE ATENçãO". A presente invenção refere-se ao uso de triazóis fluorados no tratamento da dor neuropática, distúrbios afetivos e de atenção incluindo distúrbios de humor bipolar.
BR0008606-1A 1999-03-01 2000-02-28 Uso de triazóis fluorados para tratamento de dor e distúrbios afetivos ou de atenção BR0008606A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/259,910 US6156775A (en) 1999-03-01 1999-03-01 Use of fluorinated triazoles in treating affective and attention disorders
US09/259,911 US6054471A (en) 1999-03-01 1999-03-01 Use of fluorinated triazoles in treating neuropathic pain
PCT/EP2000/001626 WO2000051577A2 (en) 1999-03-01 2000-02-28 Use of fluorinated triazoles for treating pain and affective or attention disorders

Publications (1)

Publication Number Publication Date
BR0008606A true BR0008606A (pt) 2002-01-22

Family

ID=26947613

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0008606-1A BR0008606A (pt) 1999-03-01 2000-02-28 Uso de triazóis fluorados para tratamento de dor e distúrbios afetivos ou de atenção

Country Status (25)

Country Link
EP (2) EP1156856B1 (pt)
JP (1) JP4700195B2 (pt)
KR (2) KR100839766B1 (pt)
CN (2) CN1195516C (pt)
AT (1) ATE303179T1 (pt)
AU (1) AU764508B2 (pt)
BR (1) BR0008606A (pt)
CA (1) CA2362411C (pt)
CY (1) CY1115241T1 (pt)
DE (1) DE60022317T2 (pt)
DK (2) DK1609505T3 (pt)
ES (2) ES2244413T3 (pt)
HK (1) HK1086775A1 (pt)
HU (2) HU227602B1 (pt)
ID (1) ID29891A (pt)
IL (3) IL144852A0 (pt)
NO (2) NO328927B1 (pt)
NZ (1) NZ513716A (pt)
PL (2) PL197158B1 (pt)
PT (1) PT1609505E (pt)
RU (1) RU2238725C2 (pt)
SI (1) SI1609505T1 (pt)
SK (2) SK286203B6 (pt)
TW (1) TW513301B (pt)
WO (1) WO2000051577A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3250563B1 (en) 2015-01-30 2022-01-12 Neurocrine Biosciences, Inc. Substituted triazoles and methods relating thereto

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1511195A (en) * 1976-10-18 1978-05-17 Ici America Inc Triazole derivatives
PH22568A (en) 1985-04-18 1988-10-17 Ciba Geigy Ag Fluorinated benzyl triazoles and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
EP1156856B1 (en) 2005-08-31
KR20080003944A (ko) 2008-01-08
AU3425300A (en) 2000-09-21
CN1636562A (zh) 2005-07-13
WO2000051577A2 (en) 2000-09-08
HU227602B1 (en) 2011-09-28
PL199660B1 (pl) 2008-10-31
NO334104B1 (no) 2013-12-09
SK286203B6 (sk) 2008-05-06
KR100839766B1 (ko) 2008-06-20
ES2244413T3 (es) 2005-12-16
KR20010108285A (ko) 2001-12-07
ES2441208T3 (es) 2014-02-03
DE60022317D1 (de) 2005-10-06
CY1115241T1 (el) 2017-01-04
SK286775B6 (sk) 2009-05-07
SK12252001A3 (sk) 2002-05-09
WO2000051577A3 (en) 2001-01-25
RU2238725C2 (ru) 2004-10-27
PL350418A1 (en) 2002-12-16
KR100839765B1 (ko) 2008-06-20
EP1156856A2 (en) 2001-11-28
HK1086775A1 (en) 2006-09-29
SI1609505T1 (sl) 2014-03-31
DK1156856T3 (da) 2005-10-31
ATE303179T1 (de) 2005-09-15
CN1195516C (zh) 2005-04-06
NO20014180L (no) 2001-08-28
ID29891A (id) 2001-10-18
NO20092921L (no) 2001-08-28
HUP0302780A3 (en) 2004-10-28
JP4700195B2 (ja) 2011-06-15
CA2362411A1 (en) 2000-09-08
NO20014180D0 (no) 2001-08-28
JP2002538100A (ja) 2002-11-12
NZ513716A (en) 2003-10-31
EP1609505A1 (en) 2005-12-28
HU1000576D0 (en) 2010-12-28
PL197158B1 (pl) 2008-03-31
IL144852A0 (en) 2002-06-30
PT1609505E (pt) 2014-02-24
HU230044B1 (hu) 2015-05-28
NO328927B1 (no) 2010-06-14
CA2362411C (en) 2009-11-24
IL144852A (en) 2008-11-26
DK1609505T3 (en) 2014-02-17
DE60022317T2 (de) 2006-06-01
IL189190A0 (en) 2008-06-05
HUP0302780A2 (hu) 2003-12-29
EP1609505B1 (en) 2013-12-11
AU764508B2 (en) 2003-08-21
TW513301B (en) 2002-12-11
CN1356916A (zh) 2002-07-03

Similar Documents

Publication Publication Date Title
DE60239612D1 (de) Monodisperse mischungen und verfahren zur behandlung von diabetes
BR9811946A (pt) Método para prevenção ou tratamento de distúrbios e doenças dependentes de estrogênio
BRPI0313792B8 (pt) utilização de proteína de eritropoetina, método para tratamento de distúrbios de distribuição de ferro em diabetes e medicamento para o seu tratamento
BR9914735A (pt) Processo para tratamento de sépsia
ATE214272T1 (de) Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
BRPI0408491A (pt) tratamento da doença de alzheimer
HK1068350A1 (en) Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain
HK1037980A1 (en) Use of selegiline or desmethylselegiline for the manufacture of a medicament for treating wounds, burns or photodamage.
ATE310517T1 (de) Cabergolin und pramipexol zur behandlung von krankheiten des zentralnervensystems, insbesondere parkinsonscher krankheit
BR0008606A (pt) Uso de triazóis fluorados para tratamento de dor e distúrbios afetivos ou de atenção
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
ATE428470T1 (de) Heilmittel zur behandlung von erkrankungen des sehnervs
MXPA04010816A (es) Acidos aminoalcanfosfonicos sustituidos para el tratamiento de dolor neuropatico, trastornos afectivos y de la atencion, esquizofrenia, tinitus, miopia y otros trastornos oculares.
DE69900774D1 (de) Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen
BR0311180A (pt) Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos
PT1282414E (pt) Compostos derivados de felbamato para o tratamento da dor neuropatica
AU2001276323A1 (en) Use of n-oleoylethanolamine for treating psoriasis
PT1233748E (pt) Associacao de retinal e aldeidos com actividade antifungica
PT1133297E (pt) Nova aplicacao terapeutica da 1,6-dimetil-8beta-hidroximetil-10alfa-metoxiergolina
ZA200107138B (en) Use of fluorinated triazoles for treating pain and affective or attention disorders.
EA200001091A1 (ru) Способ лечения заболеваний, связанных с образованием конкрементов

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 10 ( VIII ), 24 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]